Albuminuria in patients with diabetes Mellitus type II. Diabetes mellitus due to underlying condition with kidney complications
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group, in addition to receiving treatment for the underlying disease that is not altered by the intervention, are treated with pentoxifylline 400 m
Iran) once a day, after meals. This treatment lasts for 12 weeks. Intervention 2: Control group: Patients in this group, in addition to receiving treatment for the underlying disease that is not alter
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Type II Diabetic Patients Proteinuria more than 150mg/24hours Microalbuminuria of more than 20 mg albumin excretion in 24 hour urine
Exclusion criteria
Exclusion criteria: Patients Suffering from Diabetic Retinopathy Hypersensitivity to pentoxifylline Pregnancy Heart failure with Ejection fraction less than 35% Any acute or febrile illness one month before induction to study Use of spironolactone Use of Warfarin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Albuminuria. Timepoint: before intervention, 12 weeks after intervention. Method of measurement: 24-hour urine collection. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShokouh Shayanpour
Ahvaz University of Medical Sciences
Outcome results
None listed